News

The fully remote trial was the first of its kind in pulmonary medicine. Participants signed up online, received inhalers by courier and met investigators via telehealth appointments up to a year ...
Lupin announced on Tuesday that it will incorporate Honeywell’s Solstice Air propellant in its next-generation respiratory inhalers ... distributed in over 100 markets, maintaining a strong ...
For specific reasons, medical professionals are recommending the use of inhalers for asthma medicine and discouraging the use of oral medications. For all latest news, follow The Daily Star's ...
As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations compared with albuterol alone for people with normally mild asthma ...
Global pharma major Lupin has firmed up its plan to use Honeywell’s Solstice Air (HFO-1234ze(E) cGMP) propellant to transform respiratory care through the development of next-generation inhalers.
2-Year U.S. Treasury Note Continuous Contract $103.266-0.094-0.09% 5-Year U.S. Treasury Note Continuous Contract $107.352-0.375-0.35% 10-Year U.S. Treasury Note Continuous Contract $109.484-0.719 ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
If you're interested in exploring more stocks under $100 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Do you think that you can’t start ...
By Gary Trust Beginning with Debby Boone’s “You Light Up My Life” in 1977, a relatively select few smashes have led the Billboard Hot 100 for at least 10 weeks. How few? Just a mere 4% of ...
AZ has said it intends to transition all of its pMDIs to the new propellant by 2030, and noted that the new Trixeo/Breztri inhaler is also under regulatory review in Europe, China, and other ...
UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler ... on track to hit 100% in 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...